Workflow
单位行贿罪
icon
Search documents
涉嫌单位行贿罪被移送起诉,信邦制药多项业务毛利率下滑
Xin Lang Cai Jing· 2025-12-19 12:48
信邦制药宣布因涉嫌单位行贿罪被移送起诉,次日股价跌停。尽管已加强成本管控,公司业绩依旧承压 《中国科技投资》何梓嫣 12月10日晚间,信邦制药(002390.SZ)发布重大事项公告,公司因涉嫌单位行贿罪被监察委员会移送检察机关审查起诉。信邦制药此次被起诉,或与其 早年并购控股子公司贵州科开医药有限公司(下称"科开医药")事宜有关;今年2月,贵州开阳县人民法院(下称"开阳法院")公告称,已立案受理信邦 制药前董事长、实控人安怀略行贿罪和科开医药单位行贿罪一案。受上述消息影响,信邦制药12月11日股价由前日的涨停变为跌停,报收3.74元/股。 除此之外,公司经营基本面亦面临多重挑战。财务数据显示,信邦制药持续实行成本管控,但近年业绩仍未能止跌。单位行贿起诉案件的发酵,不仅对公 司业务拓展及经营产生一定影响,业绩可持续性也面临考验。 市场猜测,此次信邦制药被起诉,或与其子公司科开医药、前董事长安怀略早前涉及的行贿案件有关。 2024年3月,原贵阳医学院附属医院党委副书记、院长王小林因涉嫌严重违纪违法被查。2025年1月17日,贵州省纪委监委网站发布《纵深推进—贵州正风 肃纪反腐》专题片,公开了王小林与科开医药并购事 ...
信邦制药涉单位行贿被审查起诉,核心子公司与旧案交织凸显多重风险
Xin Lang Cai Jing· 2025-12-17 07:07
登录新浪财经APP 搜索【信披】查看更多考评等级 12月10日晚间,信邦制药发布公告称,公司收到检察机关《审查起诉阶段委托辩护人/申请法律援助告 知书》等文件,公司涉嫌单位行贿案已被监察委员会移送检察机关审查起诉。尽管公司表示当前经营正 常、管理层正常履职,但结合其子公司科开医药此前已被立案、前董事长牵涉医疗腐败案等一系列事 件,信邦制药正面临法律、经营与治理层面的多重压力。 法律风险悬顶,双罚制或致单位与个人同受罚 贵州省纪委监委在反腐专题片中披露,贵阳医学院附属医院原院长王小林受贿案中,涉及企业背景、并 购经过及相关人员身份与科开医药、信邦制药前董事长张观福、安怀略高度吻合。王小林在片中称,在 科开医药并购过程中,安某某(被指为安怀略)与张某某(被指为张观福)共同劝说其改变与国药合作 的原计划,转而支持由信邦制药收购,王小林因此收受巨额财物。 尽管安怀略已辞职并由其女儿安吉接任董事长,但其在关键历史交易中的角色以及当前司法案件中的涉 案嫌疑,仍为公司的治理透明度与独立性蒙上阴影。 当前,信邦制药自身经营亦面临压力。2025年三季报显示,公司前三季度营收42.66亿元,同比下滑 6.55%;净利润1.52亿 ...
连续两日股价大跌 信邦制药涉嫌单位行贿罪被起诉
Bei Ke Cai Jing· 2025-12-15 01:39
因涉嫌单位行贿一案被起诉,信邦制药连续两日股价下跌。 12月12日,信邦制药股价收跌9.89%,报3.37元/股。此前一日,公司股价收盘跌停。两日之间,公司市 值缩水15亿元。 新京报贝壳财经记者梳理发现,今年3月,公司前董事长安怀略、重要子公司科开医药已因涉嫌单位行 贿罪被立案受理。公开信息显示,相关事项指向信邦制药对科开医药的收购事宜。 北京市盈科律师事务所大部门副主任杜鹃对贝壳财经记者表示,单位行贿罪是指单位为谋取不正当利益 而行贿,或者违反国家规定,给予国家工作人员以回扣、手续费,且情节严重的行为。 针对该事件对公司的影响,信邦制药称,本次重大事项对公司的品牌声誉、业务拓展及未来发展可能会 产生一定的不利影响,公司管理层将积极应对可能发生的危机和风险。目前本案处于审查起诉阶段,最 终结果以司法机关出具的法律文书为准。 上海赵洪升律师事务所主任赵洪升指出,若单位行贿罪成立,上市公司除可能被判处罚金外,还可能面 临一系列衍生法律责任。若相关行贿行为导致上市公司信息披露失实,公司或需对受损投资者承担民事 赔偿责任,相关董事、监事、高级管理人员及控股股东等或承担连带赔偿责任;同时,公司可能面临行 政罚款及监管 ...
信邦制药回应卷入单位行贿案:告知书发自贵州,暂不清楚是否关联已披露案件
Xin Lang Cai Jing· 2025-12-11 10:49
智通财经记者 | 李科文 智通财经编辑 | 谢欣 12月10日晚间,信邦制药公告,公司收到检察机关《审查起诉阶段委托辩护人/申请法律援助告知 书》、《犯罪嫌疑人诉讼权利义务告知书》,主要内容为:对公司涉嫌单位行贿案,检察机关已经收到 监察委员会移送起诉的材料。 就在前一交易日,信邦制药实现放量涨停,以4.15元/股涨停收盘,成交金额突破6亿,总市值升至80.67 亿元。不过今日收盘,信邦制药报3.74元/股,跌9.88%,总市值72.7亿元。 12月11日,智通财经记者致电信邦制药董秘办。信邦制药董秘办相关工作人员向智通财经记者表示,此 次告知书由贵州方面发出,但更具体的信息暂不方便透露。公司在昨日接到告知书时,其中内未包含涉 案背景信息,目前仍在等待律师按程序推进,以便进一步了解情况。 该工作人员向智通财经记者表示,现阶段公司管理层正常履职,内部未出现违规违纪情形。公司经营在 持续进行,业务影响与公告一致。该事项可能对公司品牌声誉、业务拓展及未来发展产生影响。 12月11日,北京德恒律师事务所合伙人、德恒证券合规与监管法律服务中心副秘书长周永强向智通财经 表示,根据《刑法》相关规定,如果上市公司最终被认定构 ...
豪尔赛信披违规遭查 行贿案波澜再起 近五年扣非亏3.65亿
Chang Jiang Shang Bao· 2025-11-26 09:12
Core Viewpoint - The company Haosai (002963.SZ) is facing severe challenges due to high judicial risks and ongoing operational losses, compounded by recent legal issues and regulatory scrutiny [1][2]. Legal Issues - Haosai has been under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, leading to a formal case being opened against the company [2][4]. - The company was fined 7 million yuan for unit bribery, and its former chairman, Dai Baolin, received a three-year prison sentence with a four-year probation and a fine of 3 million yuan [2][5]. - The CSRC issued a warning to Haosai in August for failing to disclose the investigation into the bribery case, highlighting deficiencies in corporate governance and internal controls [2][9]. Management Changes - Dai Baolin resigned as chairman just before his arrest, citing retirement age, and transferred his voting rights to his son, Dai Congqi, marking a change in control amid ongoing legal troubles [5][7]. - The new leadership under Dai Congqi faces significant challenges, including unresolved lawsuits, regulatory investigations, and declining performance [3][7]. Financial Performance - Haosai has experienced a dramatic decline in financial performance since 2020, with cumulative net losses of 365 million yuan over the past five years, particularly in the non-recurring profit category [8][9]. - For the first three quarters of 2025, the company reported a revenue of 265 million yuan, a year-on-year decrease of 29.79%, and a net loss of 26.31 million yuan, a staggering decline of 523.96% [8][9]. - The company attributes its financial struggles to fluctuations in demand within the lighting engineering sector, intensified competition, rising costs, and extended customer payment cycles [8].
豪尔赛信披违规遭查行贿案波澜再起 近五年扣非亏3.65亿戴聪棋接班待考
Chang Jiang Shang Bao· 2025-11-25 23:35
Core Viewpoint - Haosai (002963.SZ) is facing severe challenges due to high judicial risks and ongoing operational losses, compounded by recent legal issues and regulatory scrutiny [1][2]. Group 1: Legal and Regulatory Issues - The China Securities Regulatory Commission (CSRC) has initiated an investigation into Haosai for suspected violations of information disclosure laws [2][4]. - Haosai's former chairman, Dai Baolin, was sentenced to three years in prison (suspended for four years) and fined 3 million yuan for bribery, while the company was fined 7 million yuan for the same offense [2][5]. - The CSRC's investigation follows a warning issued by the Beijing Securities Regulatory Bureau regarding deficiencies in the company's governance and internal controls [9]. Group 2: Financial Performance - Haosai has reported a cumulative net loss of 365 million yuan (approximately 3.65 billion yuan) in net profit after deducting non-recurring gains and losses over the past five years [8][9]. - The company's revenue has significantly declined from 11.57 billion yuan in its first year of listing to 2.65 billion yuan in the first three quarters of 2025, representing a year-on-year decrease of 29.79% [8]. - The net profit for the first three quarters of 2025 showed a loss of 26.31 million yuan, a staggering decline of 523.96% compared to the previous year [8]. Group 3: Management and Control Changes - Dai Baolin resigned as chairman just before his arrest, transferring his voting rights to his son, Dai Congqi, marking a significant change in control amid ongoing legal troubles [7][8]. - The new management under Dai Congqi faces multiple challenges, including unresolved lawsuits, regulatory investigations, and declining performance [7][8].
豪尔赛:从冬奥“雪如意”功臣到多重危机缠身
Zhong Jin Zai Xian· 2025-11-25 10:55
Core Viewpoint - Haosai, a leading lighting engineering company, is currently facing significant legal and regulatory challenges, including an investigation by the China Securities Regulatory Commission (CSRC) for information disclosure violations, following a recent bribery case involving its former chairman [1][2]. Group 1: Legal and Regulatory Issues - The CSRC has initiated an investigation into Haosai for suspected violations of information disclosure laws, which follows the company's delayed reporting of its former chairman's legal troubles [1]. - The former chairman, Dai Baolin, was arrested in June 2025, but Haosai only disclosed this information in August 2025, leading to regulatory scrutiny and warnings from the Beijing Securities Regulatory Bureau and the Shenzhen Stock Exchange [1]. - The company is also dealing with a bribery case where it was fined 7 million yuan, and Dai Baolin received a three-year prison sentence with a four-year probation [2]. Group 2: Financial Performance - Haosai reported a significant decline in financial performance, with revenues of 265 million yuan for the first three quarters of 2025, a year-on-year decrease of 29.79%, and a net loss of 26.31 million yuan, representing a 524% increase in losses [3]. - Following the announcement of the CSRC investigation, Haosai's stock price fell by 5.32% on November 22, 2025, and the company's market capitalization has significantly decreased since its peak in 2019 [3]. Group 3: Management Changes - In July 2025, Haosai underwent a change in control as Dai Baolin transferred voting rights of his shares to his son, Dai Congqi, marking a generational shift in leadership [2]. - Despite the change in control, the company's operational challenges have persisted, and the new management has not yet reversed the declining trend in performance [3][4]. Group 4: Market Reactions - The market response to Haosai's situation has been mixed, with some investors expressing optimism about potential recovery, while others remain cautious and expect further declines in stock value [5].
2家A股公司,被证监会立案!
券商中国· 2025-11-21 12:27
2家上市公司,公告被证监会立案。 11月21日晚,聚石化学(688669)公告称,公司于2025年11月21日收到中国证监会下发的《立案告知书》,因公司涉嫌信息披露违法违规,中国证监会决定对 公司立案。 聚石化学称,目前公司各项经营活动和业务均正常开展,将积极配合中国证监会的相关工作,并及时履行信息披露义务。 同日,豪尔赛(002963)公告,公司于近日收到中国证监会下发的《立案告知书》,因涉嫌信息披露违法违规,根据《中华人民共和国证券法》《中华人民共和 国行政处罚法》等法律法规,中国证监会对公司进行立案。 值得注意的是,豪尔赛曾于2025年7月29日公告,公司实际控制人之一戴宝林为支持戴聪棋作为上市公司控股股东暨实际控制人行使股东权利,更好地行使公司经 营管理及重大事项决策权,与戴聪棋签署了《关于豪尔赛科技集团股份有限公司之表决权委托协议》,将持有的公司3512.84万股股份(占公司总股本的 23.36%)对应的全部表决权、召集权、提名和提案权、参会权、监督建议权以及除收益权和股份转让权等财产性权利之外的其他权利独家委托给戴聪棋行使。本 次表决权委托后,公司控股股东、实际控制人变更为戴聪棋和刘清梅;戴宝林、 ...
豪尔赛前董事长被“判三缓四”,检察院抗诉:判轻了
Shen Zhen Shang Bao· 2025-11-17 06:21
Core Viewpoint - The company, Haosai Technology Group Co., Ltd., is facing legal challenges due to bribery charges against its former chairman, Dai Baolin, which has resulted in significant penalties and an ongoing appeal process [1][2]. Legal Proceedings - The company was fined 7 million RMB for unit bribery, while Dai Baolin received a three-year prison sentence with a four-year probation and a fine of 3 million RMB [2]. - The Hubei Province Wuhan New District People's Procuratorate has filed an appeal against the leniency of the sentence, indicating potential changes in the final judgment [1][2]. Company Management Changes - Dai Baolin is no longer in any core positions within the company following the investigation and legal proceedings [1][3]. - The company has undergone management changes, with Dai Baolin previously serving as both chairman and general manager during the investigation period [3]. Financial Performance - For the first three quarters of 2025, the company reported revenues of 265 million RMB, a year-on-year decline of 29.79%, with a net loss of 26 million RMB [3]. - In the third quarter, the company achieved revenues of 107 million RMB, reflecting a year-on-year growth of 31.34%, and a net profit of 7.4 million RMB, indicating a turnaround from previous losses [3]. Industry Context - The decline in revenue is attributed to adjustments in investment rhythms in the infrastructure and real estate sectors, leading to a temporary fluctuation in demand within the lighting engineering industry [3].
豪尔赛创始人被“判三缓四罚300万元”,36岁儿子此前已接班,股价刚涨停
Mei Ri Jing Ji Xin Wen· 2025-11-16 10:55
Core Viewpoint - Haosai Technology Group Co., Ltd. is facing legal challenges due to a criminal appeal filed by the People's Procuratorate of Xinzhou District, Wuhan, regarding a bribery case involving the company and its former chairman Dai Baolin [1][4]. Legal Proceedings - The company was fined 7 million RMB for unit bribery, while Dai Baolin received a three-year prison sentence with a four-year probation and a fine of 3 million RMB [1][4]. - The court's final ruling remains uncertain due to the ongoing appeal process initiated by the procuratorate, which argues that the initial sentence was too lenient [1]. Financial Impact - The fines and the amount to be returned to the state total approximately 28.52 million RMB, which represents 15.90% of the company's most recent audited net profit attributable to shareholders [5]. - The company reported a net profit of -26.31 million RMB for the first three quarters of 2025, a decline of 523.96% year-on-year [10][11]. Stock Performance - Haosai's stock has shown significant volatility, with a recent price of 19.17 RMB, reflecting a 44% increase over the past month and a 67% increase year-to-date [7]. - The company went public on October 28, 2019, with an initial offering price of 23.66 RMB per share, but has since experienced a decline in stock value [7]. Management Changes - Following legal issues, Dai Baolin resigned from his positions as chairman and general manager, with his son Dai Congqi taking over as the new chairman [6].